Impaired mTORC1-Dependent Expression of Homer-3 Influences SCA1 Pathophysiology

Neuron

Volumn 89, Issue 1, 2016, Pages 129-146

  Ruegsegger, Céline ^a   Stucki, David M ^a   Steiner, Silvio ^a   Angliker, Nico ^b   Radecke, Julika ^a,c   Keller, Eva ^a   Zuber, Benoît ^c   Rüegg, Markus A ^b   Saxena, Smita ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIN 1; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; METABOTROPIC RECEPTOR 1; PROTEIN HOMER 3; S6 KINASE; ATXN1 PROTEIN, MOUSE; CARRIER PROTEIN; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MULTIPROTEIN COMPLEX; NERVE PROTEIN; PROTEIN HOMER; TARGET OF RAPAMYCIN KINASE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CELL MATURATION; CONTROLLED STUDY; GLUTAMATERGIC SYNAPSE; GRANULE CELL; IMMUNOBLOTTING; MASS SPECTROMETRY; MOUSE; NERVE CELL EXCITABILITY; NERVE CELL STIMULATION; NONHUMAN; PATHOPHYSIOLOGY; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN TRANSPORT; PROTEOMICS; PURKINJE CELL; ROTAROD TEST; SIGNAL TRANSDUCTION; SPINOCEREBELLAR ATAXIA TYPE 1; SPINOCEREBELLAR DEGENERATION; SYNAPTIC INHIBITION; SYNAPTIC TRANSMISSION; UPREGULATION; ANIMAL; CENTRAL NERVOUS SYSTEM DISEASE; CEREBELLUM; DISEASE MODEL; GENETICS; METABOLISM; NERVE CELL; PATHOLOGY; PROCEDURES; TRANSGENIC MOUSE;

ANIMALS; ATAXIN-1; CARRIER PROTEINS; CENTRAL NERVOUS SYSTEM DISEASES; CEREBELLUM; DISEASE MODELS, ANIMAL; MICE, TRANSGENIC; MULTIPROTEIN COMPLEXES; NERVE TISSUE PROTEINS; NEURONS; PROTEOMICS; PURKINJE CELLS; TOR SERINE-THREONINE KINASES;

EID: 84953723019     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2015.11.033     Document Type: Article

References (55)

1. Angliker N., Burri M., Zaichuk M., Fritschy J.M., Rüegg M.A. mTORC1 and mTORC2 have largely distinct functions in Purkinje cells. Eur. J. Neurosci. 2015, 42:2595-2612.
2. Balaban C.D. Central neurotoxic effects of intraperitoneally administered 3-acetylpyridine, harmaline and niacinamide in Sprague-Dawley and Long-Evans rats: a critical review of central 3-acetylpyridine neurotoxicity. Brain Res. 1985, 356:21-42.
3. Banfi S., Servadio A., Chung M.Y., Kwiatkowski T.J., McCall A.E., Duvick L.A., Shen Y., Roth E.J., Orr H.T., Zoghbi H.Y. Identification and characterization of the gene causing type 1 spinocerebellar ataxia. Nat. Genet. 1994, 7:513-520.
4. Barnes J.A., Ebner B.A., Duvick L.A., Gao W., Chen G., Orr H.T., Ebner T.J. Abnormalities in the climbing fiber-Purkinje cell circuitry contribute to neuronal dysfunction in ATXN1[82Q] mice. J. Neurosci. 2011, 31:12778-12789.
5. Beitz A.J., Saxon D. Harmaline-induced climbing fiber activation causes amino acid and peptide release in the rodent cerebellar cortex and a unique temporal pattern of Fos expression in the olivo-cerebellar pathway. J. Neurocytol. 2004, 33:49-74.
6. Bentzinger C.F., Romanino K., Cloëtta D., Lin S., Mascarenhas J.B., Oliveri F., Xia J., Casanova E., Costa C.F., Brink M., et al. Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metab. 2008, 8:411-424.
7. Berkel S., Marshall C.R., Weiss B., Howe J., Roeth R., Moog U., Endris V., Roberts W., Szatmari P., Pinto D., et al. Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat. Genet. 2010, 42:489-491.
8. Bezprozvanny I.B. Calcium signaling and neurodegeneration. Acta Naturae 2010, 2:72-82.
9. Brakeman P.R., Lanahan A.A., O'Brien R., Roche K., Barnes C.A., Huganir R.L., Worley P.F. Homer: a protein that selectively binds metabotropic glutamate receptors. Nature 1997, 386:284-288.
10. Bürk K., Abele M., Fetter M., Dichgans J., Skalej M., Laccone F., Didierjean O., Brice A., Klockgether T. Autosomal dominant cerebellar ataxia type I clinical features and MRI in families with SCA1, SCA2 and SCA3. Brain 1996, 119:1497-1505.
11. Clark H.B., Burright E.N., Yunis W.S., Larson S., Wilcox C., Hartman B., Matilla A., Zoghbi H.Y., Orr H.T. Purkinje cell expression of a mutant allele of SCA1 in transgenic mice leads to disparate effects on motor behaviors, followed by a progressive cerebellar dysfunction and histological alterations. J. Neurosci. 1997, 17:7385-7395.
12. Crespo-Barreto J., Fryer J.D., Shaw C.A., Orr H.T., Zoghbi H.Y. Partial loss of ataxin-1 function contributes to transcriptional dysregulation in spinocerebellar ataxia type 1 pathogenesis. PLoS Genet. 2010, 6:e1001021.
13. Dussault I., Fawcett D., Matthyssen A., Bader J.A., Giguère V. Orphan nuclear receptor ROR alpha-deficient mice display the cerebellar defects of staggerer. Mech. Dev. 1998, 70:147-153.
14. Duvick L., Barnes J., Ebner B., Agrawal S., Andresen M., Lim J., Giesler G.J., Zoghbi H.Y., Orr H.T. SCA1-like disease in mice expressing wild-type ataxin-1 with a serine to aspartic acid replacement at residue 776. Neuron 2010, 67:929-935.
15. Ebner B.A., Ingram M.A., Barnes J.A., Duvick L.A., Frisch J.L., Clark H.B., Zoghbi H.Y., Ebner T.J., Orr H.T. Purkinje cell ataxin-1 modulates climbing fiber synaptic input in developing and adult mouse cerebellum. J. Neurosci. 2013, 33:5806-5820.
16. Gong R., Park C.S., Abbassi N.R., Tang S.J. Roles of glutamate receptors and the mammalian target of rapamycin (mTOR) signaling pathway in activity-dependent dendritic protein synthesis in hippocampal neurons. J. Biol. Chem. 2006, 281:18802-18815.
17. Hamdan F.F., Daoud H., Piton A., Gauthier J., Dobrzeniecka S., Krebs M.O., Joober R., Lacaille J.C., Nadeau A., Milunsky J.M., et al. De novo SYNGAP1 mutations in nonsyndromic intellectual disability and autism. Biol. Psychiatry 2011, 69:898-901.
18. Harding H.P., Atkins G.B., Jaffe A.B., Seo W.J., Lazar M.A. Transcriptional activation and repression by RORalpha, an orphan nuclear receptor required for cerebellar development. Mol. Endocrinol. 1997, 11:1737-1746.
19. Hashimoto K., Ichikawa R., Takechi H., Inoue Y., Aiba A., Sakimura K., Mishina M., Hashikawa T., Konnerth A., Watanabe M., Kano M. Roles of glutamate receptor delta 2 subunit (GluRdelta 2) and metabotropic glutamate receptor subtype 1 (mGluR1) in climbing fiber synapse elimination during postnatal cerebellar development. J. Neurosci. 2001, 21:9701-9712.
20. Hayashi M.K., Tang C., Verpelli C., Narayanan R., Stearns M.H., Xu R.M., Li H., Sala C., Hayashi Y. The postsynaptic density proteins Homer and Shank form a polymeric network structure. Cell 2009, 137:159-171.
21. Heller M., Schlappritzi E., Stalder D., Nuoffer J.M., Haeberli A. Compositional protein analysis of high density lipoproteins in hypercholesterolemia by shotgun LC-MS/MS and probabilistic peptide scoring. Mol. Cell. Proteomics 2007, 6:1059-1072.
22. Jiang Y.H., Ehlers M.D. Modeling autism by SHANK gene mutations in mice. Neuron 2013, 78:8-27.
23. Kwiatkowski D.J., Zhang H., Bandura J.L., Heiberger K.M., Glogauer M., el-Hashemite N., Onda H. A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells. Hum. Mol. Genet. 2002, 11:525-534.
24. Lam Y.C., Bowman A.B., Jafar-Nejad P., Lim J., Richman R., Fryer J.D., Hyun E.D., Duvick L.A., Orr H.T., Botas J., Zoghbi H.Y. ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology. Cell 2006, 127:1335-1347.
25. Lee J.H., Tecedor L., Chen Y.H., Monteys A.M., Sowada M.J., Thompson L.M., Davidson B.L. Reinstating aberrant mTORC1 activity in Huntington's disease mice improves disease phenotypes. Neuron 2015, 85:303-315.
26. Li Y., Wang H., Muffat J., Cheng A.W., Orlando D.A., Lovén J., Kwok S.M., Feldman D.A., Bateup H.S., Gao Q., et al. Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons. Cell Stem Cell 2013, 13:446-458.
27. Lin X., Antalffy B., Kang D., Orr H.T., Zoghbi H.Y. Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1. Nat. Neurosci. 2000, 3:157-163.
28. Llano I., Marty A., Armstrong C.M., Konnerth A. Synaptic- and agonist-induced excitatory currents of Purkinje cells in rat cerebellar slices. J. Physiol. 1991, 434:183-213.
29. Lüscher C., Huber K.M. Group 1 mGluR-dependent synaptic long-term depression: mechanisms and implications for circuitry and disease. Neuron 2010, 65:445-459.
30. Ma T., Hoeffer C.A., Capetillo-Zarate E., Yu F., Wong H., Lin M.T., Tampellini D., Klann E., Blitzer R.D., Gouras G.K. Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer's disease. PLoS ONE 2010, 5:e12845.
31. Malagelada C., Ryu E.J., Biswas S.C., Jackson-Lewis V., Greene L.A. RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson's disease by a mechanism involving mammalian target of rapamycin inactivation. J. Neurosci. 2006, 26:9996-10005.
32. Meikle L., Pollizzi K., Egnor A., Kramvis I., Lane H., Sahin M., Kwiatkowski D.J. Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function. J. Neurosci. 2008, 28:5422-5432.
33. Miller S.G., Kennedy M.B. Regulation of brain type II Ca2+/calmodulin-dependent protein kinase by autophosphorylation: a Ca2+-triggered molecular switch. Cell 1986, 44:861-870.
34. Mizutani A., Kuroda Y., Futatsugi A., Furuichi T., Mikoshiba K. Phosphorylation of Homer3 by calcium/calmodulin-dependent kinase II regulates a coupling state of its target molecules in Purkinje cells. J. Neurosci. 2008, 28:5369-5382.
35. Orr H.T., Chung M.Y., Banfi S., Kwiatkowski T.J., Servadio A., Beaudet A.L., McCall A.E., Duvick L.A., Ranum L.P., Zoghbi H.Y. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat. Genet. 1993, 4:221-226.
36. Ricciardi S., Boggio E.M., Grosso S., Lonetti G., Forlani G., Stefanelli G., Calcagno E., Morello N., Landsberger N., Biffo S., et al. Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model. Hum. Mol. Genet. 2011, 20:1182-1196.
37. Ronesi J.A., Huber K.M. Homer interactions are necessary for metabotropic glutamate receptor-induced long-term depression and translational activation. J. Neurosci. 2008, 28:543-547.
38. Ronesi J.A., Collins K.A., Hays S.A., Tsai N.-P., Guo W., Birnbaum S.G., Hu J.-H., Worley P.F., Gibson J.R., Huber K.M. Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome. Nat. Neurosci. 2012, 15:431-440, S1.
39. Roselli F., Caroni P. From intrinsic firing properties to selective neuronal vulnerability in neurodegenerative diseases. Neuron 2015, 85:901-910.
40. Saito H., Tsumura H., Otake S., Nishida A., Furukawa T., Suzuki N. L7/Pcp-2-specific expression of Cre recombinase using knock-in approach. Biochem. Biophys. Res. Commun. 2005, 331:1216-1221.
41. Saxena S., Roselli F., Singh K., Leptien K., Julien J.-P., Gros-Louis F., Caroni P. Neuroprotection through excitability and mTOR required in ALS motoneurons to delay disease and extend survival. Neuron 2013, 80:80-96.
42. Serra H.G., Byam C.E., Lande J.D., Tousey S.K., Zoghbi H.Y., Orr H.T. Gene profiling links SCA1 pathophysiology to glutamate signaling in Purkinje cells of transgenic mice. Hum. Mol. Genet. 2004, 13:2535-2543.
43. Serra H.G., Duvick L., Zu T., Carlson K., Stevens S., Jorgensen N., Lysholm A., Burright E., Zoghbi H.Y., Clark H.B., et al. RORalpha-mediated Purkinje cell development determines disease severity in adult SCA1 mice. Cell 2006, 127:697-708.
44. Shiraishi Y., Mizutani A., Yuasa S., Mikoshiba K., Furuichi T. Differential expression of Homer family proteins in the developing mouse brain. J. Comp. Neurol. 2004, 473:582-599.
45. Todd P.K., Mack K.J., Malter J.S. The fragile X mental retardation protein is required for type-I metabotropic glutamate receptor-dependent translation of PSD-95. Proc. Natl. Acad. Sci. USA 2003, 100:14374-14378.
46. Tsai P.T., Hull C., Chu Y., Greene-Colozzi E., Sadowski A.R., Leech J.M., Steinberg J., Crawley J.N., Regehr W.G., Sahin M. Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice. Nature 2012, 488:647-651.
47. Tsuda H., Jafar-Nejad H., Patel A.J., Sun Y., Chen H.K., Rose M.F., Venken K.J.T., Botas J., Orr H.T., Bellen H.J., Zoghbi H.Y. The AXH domain of Ataxin-1 mediates neurodegeneration through its interaction with Gfi-1/Senseless proteins. Cell 2005, 122:633-644.
48. Tu J.C., Xiao B., Yuan J.P., Lanahan A.A., Leoffert K., Li M., Linden D.J., Worley P.F. Homer binds a novel proline-rich motif and links group 1 metabotropic glutamate receptors with IP3 receptors. Neuron 1998, 21:717-726.
49. Watase K., Weeber E.J., Xu B., Antalffy B., Yuva-Paylor L., Hashimoto K., Kano M., Atkinson R., Sun Y., Armstrong D.L., et al. A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration. Neuron 2002, 34:905-919.
50. Weiler I.J., Spangler C.C., Klintsova A.Y., Grossman A.W., Kim S.H., Bertaina-Anglade V., Khaliq H., de Vries F.E., Lambers F.A., Hatia F., et al. Fragile X mental retardation protein is necessary for neurotransmitter-activated protein translation at synapses. Proc. Natl. Acad. Sci. USA 2004, 101:17504-17509.
51. Yates S.C., Zafar A., Hubbard P., Nagy S., Durant S., Bicknell R., Wilcock G., Christie S., Esiri M.M., Smith A.D., Nagy Z. Dysfunction of the mTOR pathway is a risk factor for Alzheimer's disease. Acta Neuropathol. Commun. 2013, 1. 10.1186/2051-5960-1-3.
52. Yue S., Serra H.G., Zoghbi H.Y., Orr H.T. The spinocerebellar ataxia type 1 protein, ataxin-1, has RNA-binding activity that is inversely affected by the length of its polyglutamine tract. Hum. Mol. Genet. 2001, 10:25-30.
53. Zoghbi H.Y., Orr H.T. Spinocerebellar ataxia type 1. Semin. Cell Biol. 1995, 6:29-35.
54. Zoghbi H.Y., Orr H.T. Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type 1. J. Biol. Chem. 2009, 284:7425-7429.
55. Zu T., Duvick L.A., Kaytor M.D., Berlinger M.S., Zoghbi H.Y., Clark H.B., Orr H.T. Recovery from polyglutamine-induced neurodegeneration in conditional SCA1 transgenic mice. J. Neurosci. 2004, 24:8853-8861.